Project Inform
   

PI Action alerts & updates ... 2006

PI ACTION UPDATE

March 9, 2006

In this issue

President Continues Attack on Health Care
HIV/AIDS Care and Treatment Still Underfunded
Part D Implementation Off to a Rocky Start
New Guidelines for Part D Formularies
CMS Gives More Time to Fill Prescriptions
California Extends Emergency Coverage for Duals
What's Happening with Ryan White Reauthorization?
California Advocates Release Budget Request
Treatment Advocacy Update
Changes ... and a Retooled Health Care Advocacy Webpage
A Quote We Like


President Continues Attack on Health Care
Just days after Congress passed the "Deficit Reduction Act" with major cuts to public health care programs, President Bush released his proposed budget for Fiscal Year 2007 and continued the attack on the nation's most vulnerable people. Read Project Inform's response to the budget proposal here.

In addition to calling for an overall cut to the Department of Health and Human Services, which funds health and social service programs nationwide, the President's budget includes $13.7 billion in new cuts to Medicaid. This is on top of the $4.8 billion cut in the 2006 budget. Last year's budget also included new power given to states to increase co-pays and other cost-sharing to their Medicaid recipients, and refuse services if beneficiaries can't pay. With the passage of the Deficit Reduction Act, the battle to maintain Medicaid programs has moved to the state level. State advocates will have to work hard to ensure that their Medicaids don't enact these harmful cost cutting measures.

While many of the cuts in the new budget are considered "administrative", the reality is that states can't absorb any more hits in their Medicaid funding. The likely result is that these cuts will be passed to the Medicaid recipient in the form of increased cost burdens.

The non-partisan Congressional Budget Office has analyzed the Deficit Reduction Act and found that 80% of the savings in Medicaid will come from denying care and treatment to those who can't pay higher co-pays and premiums. The new cuts proposed by the President will only make this situation worse. We need to tell our elected representatives "enough is enough" and stand firm against any more cuts to this lifesaving health program.

Top of page

HIV/AIDS Care and Treatment Still Underfunded
During his State of the Union address in February, President Bush stated that "A hopeful society acts boldly to fight diseases like HIV/AIDS, which can be prevented, and treated, and defeated."

His proposed budget for domestic HIV/AIDS care and treatment programs, however, fell far short of matching those strong words. Once again, the President has called for flat funding for all of the Ryan White CARE Act, with a couple of exceptions. This will make it even harder for people with HIV around the country to get vital primary care and support services.

The President called for a $70 million increase to help states with ADAP waiting lists. While this funding is badly needed, it falls short of the $197 million increase identified by treatment experts as the amount that will help states provide a basic level of service to everyone who needs it. It also means that states without waiting lists, many of which are still in severe need, won't receive any extra money, potentially creating more problems with their ADAPs.

The budget also asks for $25 million for outreach efforts by faith and community-based organizations to reach underserved populations. While the money is proposed to go through the CARE Act, details are still unknown. Although outreach is clearly important, outreach without sustaining necessary health care and support services is wasted money and bad public health.

In addition to continuing our calls, letters, and meetings with elected representatives to fight for adequate HIV/AIDS and health care money, with mid-term elections coming up in November, we have a great opportunity to make sure we are electing Members of Congress who commit to making health care a priority. In the next few months, look for ways you can get involved in talking to candidates about issues important to us and in helping others register to vote and getting to the polls.

Top of page

Part D Implementation Off to a Rocky Start
Medicare's new prescription drug benefit, Medicare Part D, started on January 1, 2006. Among the first to enter the benefit were the approximately 7.4 million beneficiaries who qualify for Medicare and Medicaid (known as dual eligibles). These include the 70 to 85 percent of Medicare beneficiaries living with AIDS. The dual eligibles lost their Medicaid prescription drug coverage on December 31, 2005 and should have been automatically enrolled in a Medicare Part D plan on January 1,2006.

Dual eligibles are among the sickest and lowest income of all Medicare beneficiaries. Over half are in fair or poor health and they are more likely to have mental health concerns and to live in nursing homes. This very vulnerable population was the wrong place to start with the launch of a new and untested benefit system. Advocates have been warning elected officials, the administration and the Centers for Medicaid and Medicare Services (CMS) that this population would likely have a very difficult time under the new benefit, especially because it is delivered by private companies with little to no experience with a high-need population.

Unfortunately, this group was among the first to be forced into the benefit. Implementation was plagued with problems, including impossible wait times for help, inaccurate information on beneficiaries plans and benefits, and customer representatives who had incorrect information. The result was hundreds of thousands dual eligibles without access to the drugs they needed. Project Inform has prepared an article with detailed information on implementation, and some tips for those can't access their medication.

Top of page

New Guidelines for Part D Formularies
The HIV Medicaid and Medicare Work Group recently sent comments to the Centers for Medicaid and Medicare Services (CMS) on the proposed guidelines for Medicare Part D formularies. While we are pleased that CMS is continuing to "protect" six important categories of drugs, including anti-retrovirals, we are concerned that there are no requirements to add newly approved drugs to formularies upon FDA approval after April, 2006. Drugs approved after April will go through a standard plan approval process which could take up to six months.

Medicare beneficiaries living with AIDS are particularly vulnerable to delays for new drugs as they are a more treatment-experienced population who have often exhausted existing options and need access to newer options.

Top of page

CMS Gives More Time to Fill Prescriptions
All Medicare Part D plans were supposed to allow new beneficiaries a "transition" period for prescription fill. If a beneficiary was on treatment when he or she entered a new plan, all drugs were supposed to be covered for 30 days regardless of whether they were on the plan formulary. Unfortunately, plans were not honoring the transition fills and - perhaps even more problematic - beneficiaries, providers and pharmacists were mostly unaware of transition rights or how to invoke them.

The Centers for Medicaid and Medicare Services has recognized the situation and belatedly issued a memo that calls for a "one-time across the board extension of the transition period to March 31 for those individuals who were enrolled in the first few months of the program." For individuals who enroll on March 1 or thereafter, the thirty day transition policy remains in place. Part D plans were required to respond to CMS by February 6 as to whether they would implement the policy.

Top of page

California Extends Emergency Coverage for Duals
California's state-funded emergency drug coverage for dual eligibles was extended by Governor Schwarzenegger until March 16th, 2006. The Governor has the discretion under recently passed legislation to extend the coverage for thirty day increments, not beyond May 16th, 2006..

Medi-Cal (California's Medicaid) will provide drug coverage for a dual eligible when: (1) the Part D plan has denied payment for reasons other than pharmacy error, lack of medical necessity, or health and safety reasons; (2) the pharmacy can't submit a claim because Part D information is inadequate; (3) the Part D plan requires a deductible or a co-pay higher than what should be charged to a dual eligible beneficiary -- between $1 and $5 under the low-income subsidy or extra help.

For complete detailed information on how to submit claims, go to Medi-Cal's website.

Top of page

What's Happening with Ryan White Reauthorization?
The Ryan White CARE Act, which funds care, treatment, and support services to people with HIV/AIDS nationwide, expired on September 30, 2005, and needs to be reauthorized. It continues to be funded, however. Advocates have created a fact sheet with basic information about reauthorization and the process to date.

Staff of the House and Senate committees that oversee the CARE Act are meeting regularly in a bipartisan process to draft a reauthorization bill. Last week, Senator Tom Coburn (R-OK) released his own bill.

Project Inform has been working with many coalition partners to reauthorize the CARE Act, including Communities Advocating Emergency AIDS Relief (CAEAR) Coalition, and the Federal AIDS Policy Partnership (FAPP) Ryan White Reauthorization Group.

We are also advocating, along with colleagues who participated in a "Ryan White Unity Summit" last November, for a mechanism in the reauthorized bill that would provide supplemental Title II funding to states without Title I EMAs, or whose AIDS caseloads are outside of urban areas. We have released a statement for organizations and individuals to sign in support of this proposal.

Top of page

California Advocates Release Budget Request
The California Alliance of HIV Advocates, which includes Project Inform, has released its Fiscal Year 2006-2007 state budget request. It thanks the Governor and Legislature for fully funding the state's ADAP, and requests a transfer of funds from ADAP to the CARE - Health Insurance Premium Program (CARE-HIPP) to pay for premiums associated with the new Medicare prescription drug benefit. It also proposes an expansion of the CARE-HIPP to better serve people with HIV/AIDS in California.

The Alliance is asking for funding for treatment and prevention programs to address the use of methamphetamine among gay men and men who have sex with men, particularly those who are also HIV positive, and an extension of a one time increase of HIV prevention funding approved in last year's budget.

Top of page

Treatment Advocacy Update
Recent events in treatment advocacy at Project Inform include work with two key pharmaceutical companies and an exciting collaboration with the Elizabeth Taylor AIDS Foundation to bring HIV medical care to people in the hurricane ravaged area around New Orleans.

We've worked collaboratively and privately with Tibotec, a new company soon to get approval of its first product for HIV, and with Merck, one of the pioneers of protease inhibitors.

Merck is about to pioneer another new field of drugs for HIV called integrase inhibitors. Tibotec is in the final stages of testing the new protease inhibitor TMC114, also known as Darunavir. We have worked with other groups to make sure people in need have wide access to the drug without waiting for final approval.

Most importantly, the community has worked with the companies to make it possible for people in studies and in expanded access programs to get two new drugs at the same time, greatly increasing chances of success. Tibotec and Merck will also make sure that each company's new drug could be used along with the other company's. Project Inform has begun working with both companies to try to restrain the prices that will be charged for these drugs.

Beginning last October, Project Inform began a collaboration with the Elizabeth Taylor AIDS Foundation (ETAF) to help people with HIV in the New Orleans area, where nearly all the HIV clinics had been closed by the flooding. With the financial backing of ETAF, Project Inform consulted with the New Orleans AIDS Task Force to define the local need. This led to the construction of a mobile medical unit (the equivalent of two medical offices) that will be utilized throughout New Orleans and the surrounding area, bringing HIV treatment and care to those in need.

The unit, called the CARE VAN, was finished in mid February, and is currently in use. It will be shared by the Task Force, the State Department of Public Health and the Department of Public Health of the City of New Orleans. It was a rare honor and privilege to work with ETAF and with Elizabeth Taylor, a pioneer in both philanthropy and AIDS activism since the earliest days.

Top of page

Changes ... and a Retooled Health Care Advocacy Webpage
Project Inform has recently renamed its public policy department to better reflect its mission. Our Health Care Advocacy program works to protect and expand access to quality health care and treatment for people with HIV/AIDS, with a focus on vulnerable populations. To learn more about our priority issues, check out our new Health Care Advocacy webpage.

We've also retired the name of our grassroots network after a 15 year run. The Treatment Action Network (TAN) is now called PI Action. This network of people across the country continues to make a difference by urging their elected representatives to commit to a true fight against HIV/AIDS and to protect the health care of those in need. Please ask your friends and family to join in this effort and to receive our information updates by signing up for PI Action!

Top of page

A Quote We Like
"It is scandalous to provide insufficient funding for our Nation's two greatest capital investments: health and education."

Senator Arlen Specter (R-PA), February 6, 2006,
responding to the President's budget proposal

Top of page

ARCHIVES OF
ALERTS / UPDATES

2008

2007     2006

2005     2004

2003     2002

2001     2000

1999     1998

1997     1996

 
     
 

© 2008 Project Inform  1375 Mission Street,  San Francisco, CA 94103  415-558-8669
National HIV/AIDS Treatment Hotline 1-800-822-7422 (415-558-9051 local/int'l) 10a-4p Mon-Fri PST